<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="4dc2ec1d-ed65-481b-bc48-fae589eae213"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="Human Prescription Drug Label"/>
   <title>These highlights do not include all the information needed to use GRANISETRON HYDROCHLORIDE INJECTIONÂ safely and effectively. See full prescribing information for GRANISETRON HYDROCHLORIDE INJECTION.<br/>
      <br/> GRANISETRON HYDROCHLORIDE injection, for intravenous use<br/> Initial U.S. Approval: 1993</title>
   <effectiveTime value="20250424"/>
   <setId root="783e9d68-2371-4fd4-8d7a-a5e36f8718d0"/>
   <versionNumber value="5"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id root="1.3.6.1.4.1.519.1" extension="968961354"/>
            <name>Eugia US LLC</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="650498244" root="1.3.6.1.4.1.519.1"/>
                        <name>EUGIA PHARMA SPECIALITIES LIMITED</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-175" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C25391" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANALYSIS"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-176" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-175" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="MANUFACTURE"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-176" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-175" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84731" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="PACK"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="55150-176" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="1c9e324c-6caf-473f-89e6-76440d8d0cd1"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL PRODUCT DATA ELEMENTS SECTION"/>
               <effectiveTime value="20250424"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55150-175" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Granisetron Hydrochloride<suffix/>
                        </name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Granisetron Hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator value="1" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="318F6L70J8" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GRANISETRON HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="WZG3J2MCOL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GRANISETRON</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2968PHW8QP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CITRIC ACID MONOHYDRATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="A2I8C7HI9T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>METHYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Z8IX2SC1OH" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="1" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43215" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL, SINGLE-DOSE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55150-175-01" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20160706"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA204238" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20160706"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="55150-176" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Granisetron Hydrochloride<suffix/>
                        </name>
                        <formCode code="C42945" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INJECTION, SOLUTION"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Granisetron Hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIM">
                           <quantity>
                              <numerator value="4" unit="mg"/>
                              <denominator value="4" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="318F6L70J8" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GRANISETRON HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="WZG3J2MCOL" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>GRANISETRON</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2968PHW8QP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>CITRIC ACID MONOHYDRATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="A2I8C7HI9T" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>METHYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="Z8IX2SC1OH" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>PROPYLPARABEN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="4" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C43210" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="VIAL, MULTI-DOSE"/>
                              <asContent>
                                 <quantity>
                                    <numerator value="1" unit="1"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="55150-176-04" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20160706"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA204238" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20160706"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="INTRAVENOUS"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="Section_1">
               <id root="dd5f5e20-ea74-4795-95ca-7c84b61e63f2"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="Indications &amp; Usage Section"/>
               <title>1 INDICATIONS AND USAGE</title>
               <text>
                  <br/>
                  <paragraph>Granisetron hydrochloride injection, Â is a serotonin-3 (5-HT<sub>3</sub>) receptor antagonist indicated for:</paragraph>
                  <br/>
                  <list listType="unordered" styleCode="disc">
                     <item>The prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin.</item>
                     <item>The prevention and treatment of postoperative nausea and vomiting in adults. As with other antiemetics, routine prophylaxis is not recommended in patients in whom there is little expectation that nausea and/or vomiting will occur postoperatively. In patients where nausea and/or vomiting must be avoided during the postoperative period, granisetron hydrochloride injection is recommended even where the incidence of postoperative nausea and/or vomiting is low.Â </item>
                  </list>
               </text>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>Granisetron hydrochloride injection, is a serotonin-3 (5-HT<sub>3</sub>) receptor antagonist indicated for: </paragraph>
                        <list listType="unordered" styleCode="disc">
                           <item>Prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. (<linkHtml href="#Section_1">1</linkHtml>) </item>
                           <item>Prevention and treatment of postoperative nausea and vomiting in adults. (<linkHtml href="#Section_1">1</linkHtml>)</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="Section_2">
               <id root="60497928-0fa9-4a40-8aee-309bcac5c08a"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="Dosage &amp; Administration Section"/>
               <title>2 DOSAGE AND ADMINISTRATION</title>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Prevention of chemotherapy-induced nausea and vomiting </content>(<linkHtml href="#Section_2.1">2.1</linkHtml>):</paragraph>
                        <list listType="unordered" styleCode="disc">
                           <item>Recommended dosage is 10 mcg/kg intravenously within 30Â minutes before initiation of chemotherapy</item>
                           <item>Pediatric patients (2 to 16 years): Recommended dosage is 10Â mcg/kg</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">Prevention of postoperative nausea and vomiting</content> (<linkHtml href="#Section_2.2">2.2</linkHtml>):</paragraph>
                        <list listType="unordered" styleCode="disc">
                           <item>Recommended dosage is 1 mg, undiluted, administered intravenously over 30 seconds, before anesthetic induction or immediately before reversal of anesthesia.</item>
                        </list>
                        <paragraph>
                           <content styleCode="underline">Treatment of postoperative nausea and vomiting</content> (<linkHtml href="#Section_2.2">2.2</linkHtml>):</paragraph>
                        <list listType="unordered" styleCode="disc">
                           <item>Recommended dosage is 1 mg, undiluted, administered intravenously over 30 seconds.</item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="Section_2.1">
                     <id root="ada95595-4261-431a-96c4-1c051622f391"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>2.1 Prevention of Chemotherapy-Induced Nausea and Vomiting</title>
                     <text>
                        <br/>
                        <paragraph>
                           <content styleCode="underline">Adult Patients </content>Â <br/> The recommended dosage for granisetron hydrochloride injection, is 10 mcg/kg administered intravenously within 30 minutes before initiation of chemotherapy, and only on the day(s) chemotherapy is given.<br/>
                           <br/>
                           <content styleCode="underline">Infusion Preparation</content>
                           <content styleCode="underline">Â </content>
                           <br/> Granisetron hydrochloride injection, may be administered intravenously either undiluted over 30 seconds, or diluted with 0.9% Sodium Chloride or 5% Dextrose and infused over 5 minutes.<br/>
                           <br/>
                           <content styleCode="italics">Stability</content>Â <br/> Intravenous infusion of granisetron hydrochloride injection, should be prepared at the time of administration. However, granisetron hydrochloride injection, has been shown to be stable for at least 24 hours when diluted in 0.9% Sodium Chloride or 5% Dextrose and stored at room temperature under normal lighting conditions.<br/>
                           <br/>As a general precaution, granisetron hydrochloride injection, should not be mixed in solution with other drugs. Parenteral drug products should be inspected visually for particulate matter and discoloration before administration whenever solution and container permit.<br/>
                           <br/>
                           <content styleCode="underline">Pediatric Patients</content>
                        </paragraph>
                        <paragraph>The recommended dose in pediatric patients 2 to 16 years of age is 10 mcg/kgÂ <content styleCode="italics">[seeÂ <linkHtml href="#Section_14">Clinical Studies (14)</linkHtml>]</content>. Pediatric patients under 2 years of age have not been studied.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_2.2">
                     <id root="56c6db02-2aed-4b26-b8b5-1345957d5197"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>2.2 Prevention and Treatment of Postoperative Nausea and Vomiting</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Adult Patients<br/>
                           </content>
                           <br/> The recommended dosage for prevention of postoperative nausea and vomiting is 1 mg of granisetron hydrochloride injection, undiluted, administered intravenously over 30Â seconds, before induction of anesthesia or immediately before reversal of anesthesia.<br/>
                           <br/> The recommended dosage for the treatment of nausea and/or vomiting after surgery is 1 mg of granisetron hydrochloride injection, undiluted, administered intravenously over 30Â seconds.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_3">
               <id root="11720a7f-76f1-43d0-b5fe-25a8f5894c93"/>
               <code code="43678-2" codeSystem="2.16.840.1.113883.6.1" displayName="Dosage Forms &amp; Strengths Section"/>
               <title>3 DOSAGE FORMS AND STRENGTHS</title>
               <text>
                  <br/>
                  <paragraph>Single-Dose Vials for Injection: 1 mg/mL<br/>
                     <br/> Multiple-Dose Vials for Injection: 4 mg/4 mL</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Injection 1 mg/mL (free base). <linkHtml href="#Section_3">(3)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="Section_4">
               <id root="152a5ba2-1478-4920-ae96-78b7194f236c"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="Contraindications Section"/>
               <title>4 CONTRAINDICATIONS</title>
               <text>
                  <br/>
                  <paragraph>Granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Hypersensitivity to granisetron or to any of its components. <linkHtml href="#Section_4">(4)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="Section_5">
               <id root="2536adf0-ab7d-430c-a368-5373f54e1c76"/>
               <code code="43685-7" codeSystem="2.16.840.1.113883.6.1" displayName="Warnings And Precautions Section"/>
               <title>5 WARNINGS AND PRECAUTIONS</title>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Granisetron hydrochloride does not stimulate gastric or intestinal peristalsis and should not be used instead of nasogastric suction. <linkHtml href="#Section_5.1">(5.1)</linkHtml>
                           </item>
                           <item>QT prolongation has been reported with granisetron hydrochloride. Use with caution in patients with pre-existing arrhythmias or cardiac conduction disorders. <linkHtml href="#Section_5.2">(5.2)</linkHtml>
                           </item>
                           <item>Hypersensitivity reactions, such as anaphylaxis, shortness of breath, hypotension, and urticaria, may occur in patients with known hypersensitivity to other selective 5-HT<sub>3</sub> receptor antagonists. <linkHtml href="#Section_5.3">(5.3)</linkHtml>
                           </item>
                           <item>Serotonin syndrome has been reported with granisetron products, alone but particularly with concomitant use of serotonergic drugs. <linkHtml href="#Section_5.4">(5.4)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="Section_5.1">
                     <id root="5d26dcf7-e980-450e-be69-7fec0b1a5581"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>5.1 Gastric or Intestinal Peristalsis</title>
                     <text>
                        <br/>
                        <paragraph>Granisetron hydrochloride is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of granisetron hydrochloride in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distention.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_5.2">
                     <id root="98b089da-f665-4c85-89fc-6a37d60db825"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>5.2 Cardiovascular Events</title>
                     <text>
                        <br/>
                        <paragraph>An adequate QT assessment has not been conducted, but QT prolongation has been reported with granisetron hydrochloride. Therefore, granisetron hydrochloride should be used with caution in patients with pre-existing arrhythmias or cardiac conduction disorders, as this might lead to clinical consequences. Patients with cardiac disease, on cardio-toxic chemotherapy, with concomitant electrolyte abnormalities and/or on concomitant medications that prolong the QT interval are particularly at risk.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_5.3">
                     <id root="f51cb847-1bfa-42ec-a4c2-7f1b85999a36"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>5.3 Hypersensitivity Reactions</title>
                     <text>
                        <br/>
                        <paragraph>Hypersensitivity reactions (e.g., anaphylaxis, shortness of breath, hypotension, urticaria) may occur in patients who have exhibited hypersensitivity to other selective 5-HT<sub>3</sub> receptor antagonists.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_5.4">
                     <id root="d21f9745-1e78-4f3d-a2c6-d241a49b4402"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>5.4 Serotonin Syndrome</title>
                     <text>
                        <paragraph>The development of serotonin syndrome has been reported with 5-HT<sub>3</sub> receptor antagonists. Most reports have been associated with concomitant use of serotonergic drugs (e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), monoamine oxidase inhibitors, mirtazapine, fentanyl, lithium, tramadol, and intravenous methylene blue). Some of the reported cases were fatal. Serotonin syndrome occurring with overdose of another 5-HT<sub>3</sub> receptor antagonist alone has also been reported. The majority of reportsÂ of serotonin syndrome related to 5-HT<sub>3 </sub>receptor antagonist use occurred in a post-anesthesia care unit or an infusion center.<br/>
                           <br/> Symptoms associated with serotonin syndrome may include the following combination of signs and symptoms: mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, with or without gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea). Patients should be monitored for the emergence of serotonin syndrome, especially with concomitant use of granisetron and other serotonergic drugs. If symptoms of serotonin syndrome occur, discontinue granisetron and initiate supportive treatment. Patients should be informed of the increased risk of serotonin syndrome, especially if granisetron is used concomitantly with other serotonergic drugs <content styleCode="italics">[seeÂ <linkHtml href="#Section_7">Drug Interactions (7),</linkHtml>Â <linkHtml href="#Section_17.1">Patient Counseling Information (17.1)</linkHtml>].</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_6">
               <id root="2ca467f4-c015-4e9c-b3bd-07ed04c22f47"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="Adverse Reactions Section"/>
               <title>6 ADVERSE REACTIONS</title>
               <text>
                  <br/>
                  <paragraph>QT prolongation has been reported with granisetron hydrochloride <content styleCode="italics">[see <linkHtml href="#Section_5.2">Warnings and Precautions (5.2)</linkHtml> and <linkHtml href="#Section_7">Drug Interactions (7)</linkHtml>]</content>.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <br/>
                        <paragraph>Most common adverse reactions:</paragraph>
                        <list listType="unordered" styleCode="disc">
                           <item>Chemotherapy-induced nausea and vomiting (â¥ 3%): Headache, and constipation <linkHtml href="#Section_6.1">(6.1)</linkHtml>
                           </item>
                           <item>Postoperative nausea and vomiting (â¥ 2%): Pain, headache, fever, abdominal pain and hepatic enzymes increased (<linkHtml href="#Section_6.1">6.1</linkHtml>)Â </item>
                        </list>
                        <paragraph>
                           <content styleCode="bold">To report SUSPECTED ADVERSE REACTIONS, contact Eugia US LLC at 1-866-850-2876 or FDA at 1-800-FDA-1088 or <linkHtml href="http://www.fda.gov/medwatch">www.fda.gov/medwatch</linkHtml>.</content>
                        </paragraph>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="Section_6.1">
                     <id root="2aec60c7-3fe6-4a71-8433-22f50220f20e"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>6.1 Clinical Trials Experience</title>
                     <text>
                        <br/>
                        <paragraph>Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in patients. <content styleCode="underline">
                              <br/>
                              <br/> Chemotherapy-Induced Nausea and Vomiting<br/>
                           </content>
                           <br/>
                           <br/> The following have been reported during controlled clinical trials or in the routine management of patients. The percentage figures are based on clinical trial experience only. Table 1 gives the comparative frequencies of the two most commonly reported adverse reactions (â¥ 3%) in patients receiving granisetron hydrochloride injection, in single-day chemotherapy trials. These patients received chemotherapy, primarily cisplatin, and intravenous fluids during the 24-hour period following granisetron hydrochloride injection administration. Reactions were generally recorded over seven days post-granisetron hydrochloride injection administration.</paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="813.96">
                           <caption>Table 1 Principal Adverse Reactions in Clinical Trials â Single-Day Chemotherapy 
			</caption>
                           <colgroup>
                              <col width="22.5490196078431%"/>
                              <col width="44.7712418300654%"/>
                              <col width="32.6797385620915%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="3">
                                    <sup>1</sup> Metoclopramide/dexamethasone and phenothiazines/dexamethasone.<br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3" valign="top">
                                    <content styleCode="bold">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Percent of Patients With Reaction</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"> G</content>
                                    <content styleCode="bold">ranisetron Hydrochlorid</content>
                                    <content styleCode="bold">e Injection</content>
                                    <br/>
                                    <content styleCode="bold">40 mcg/kg</content>
                                    <br/>
                                    <content styleCode="bold">(n = 1268)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Comparator<sup>1</sup>
                                    </content>
                                    <br/>
                                    <content styleCode="bold">(n = 422)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â Â  Headache<br/>Â Â  Constipation<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">14%<br/>3%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">6%<br/>3%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>Additional adverse events reported in clinical trials were asthenia, somnolence and diarrhea.<br/>
                           <br/> In over 3,000 patients receiving granisetron hydrochloride injection (2 to 160 mcg/kg) in single-day and multiple-day clinical trials with emetogenic cancer therapies, adverse events, other than those adverse reactions listed in Table 1, were observed; attribution of many of these events to granisetron hydrochloride is uncertain.<content styleCode="italics">
                              <br/>
                              <br/> Hepatic: </content>In comparative trials, mainly with cisplatin regimens, elevations of AST and ALT (&gt; 2 times the upper limit of normal) following administration of granisetron hydrochloride injection occurred in 2.8% and 3.3% of patients, respectively. These frequencies were not significantly different from those seen with comparators (AST: 2.1%; ALT: 2.4%).<content styleCode="italics">
                              <br/>
                              <br/> Cardiovascular: </content>Hypertension (2%); hypotension, arrhythmias such as sinus bradycardia, atrial fibrillation, varying degrees of A-V block, ventricular ectopy including non-sustained tachycardia, and ECG abnormalities have been observed rarely.<content styleCode="italics">
                              <br/>
                              <br/> Central Nervous System: </content>Agitation, anxiety, CNS stimulation and insomnia were seen in less than 2% of patients. Extrapyramidal syndrome occurred rarely and only in the presence of other drugs associated with this syndrome.<content styleCode="italics">
                              <br/>
                              <br/> Hypersensitivity: </content>Rare cases of hypersensitivity reactions, sometimes severe (e.g., anaphylaxis, shortness of breath, hypotension, urticaria) have been reported.<br/>
                           <content styleCode="italics">
                              <br/> Other: </content>Fever (3%), taste disorder (2%), skin rashes (1%). In multiple-day comparative studies, fever occurred more frequently with granisetron hydrochloride injection (8.6%) than with comparative drugs (3.4%, P &lt; 0.014), which usually included dexamethasone.<br/>
                           <content styleCode="underline">
                              <br/> Postoperative Nausea and Vomiting<br/>
                           </content>
                           <br/> The adverse reactions listed in Table 2 were reported in â¥ 2% of adults receiving granisetron hydrochloride injection 1 mg during controlled clinical trials. </paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="100%">
                           <caption>Table 2 Adverse Reactions in Controlled Clinical Trials in Postoperative Nausea and Vomiting (Reported in â¥ 2% of Adults Receiving Granisetron Hydrochloride Injection 1 mg)Â Â Â Â Â   
			</caption>
                           <colgroup>
                              <col width="42.86%"/>
                              <col width="30.96%"/>
                              <col width="26.18%"/>
                           </colgroup>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" colspan="3" align="center" valign="top">
                                    <content styleCode="bold">Percent of Patients With Reaction</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Granisetron Hydrochloride Injection</content>
                                    <br/>
                                    <content styleCode="bold">1 mg</content>
                                    <br/>
                                    <content styleCode="bold">(n=267)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                    <content styleCode="bold">(n=266)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Pain<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">10.1<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">8.3<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Headache<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">8.6<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">7.1<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Fever<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">7.9<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">4.5<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Abdominal Pain<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">6<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">6<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Hepatic Enzymes Increased<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">5.6<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">4.1<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Dizziness<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">4.1<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">3.4<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Diarrhea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">3.4<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">1.1<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Flatulence<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">3<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">3<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Dyspepsia<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">3<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">1.9<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">Oliguria<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">2.2<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">1.5<br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="middle">Coughing<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">2.2<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">1.1<br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>Additional adverse events reported in clinical trials were constipation, anemia, insomnia, bradycardia, leukocytosis, anxiety, hypotension, infection, hypertension, and urinary tract infection.<br/>
                           <br/> In a clinical study conducted in Japan, the types of adverse events differed notably from those reported above in Table 2. The adverse events in the Japanese study that occurred in â¥ 2% of patients and were more frequent with granisetron hydrochloride injection 1 mg than with placebo were: fever (56% to 50%), sputum increased (2.7% to 1.7%), and dermatitis (2.7% to 0%).</paragraph>
                        <br/>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_6.3">
                     <id root="9bd6066f-8dca-44ff-b6f9-4d021f7c3acb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>6.2 Postmarketing Experience</title>
                     <text>
                        <br/>
                        <paragraph>The following adverse reactions have been identified during post approval use of granisetron hydrochloride. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to granisetron hydrochloride exposure.<br/>
                           <br/>QT prolongation has been reported with granisetron hydrochloride <content styleCode="italics">[see <linkHtml href="#Section_5.2">Warnings and Precautions (5.2)</linkHtml> and <linkHtml href="#Section_7">Drug Interactions (7)</linkHtml>]</content>.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_7">
               <id root="d82598a6-c5e3-4f93-9f14-205427edc07b"/>
               <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="Drug Interactions Section"/>
               <title>7 DRUG INTERACTIONS</title>
               <text>
                  <br/>
                  <paragraph>Granisetron does not induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system <content styleCode="italics">in vitro</content>. There have been no definitive drug-drug interaction studies to examine pharmacokinetic or pharmacodynamic interaction with other drugs; however, in humans, granisetron hydrochloride injection has been safely administered with drugs representing benzodiazepines, neuroleptics and anti-ulcer medications commonly prescribed with antiemetic treatments. Granisetron hydrochloride injection also does not appear to interact with emetogenic cancer chemotherapies. Because granisetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of granisetron. No specific interaction studies have been conducted in anesthetized patients. In addition, the activity of the cytochrome P-450 subfamily 3A4 (involved in the metabolism of some of the main narcotic analgesic agents) is not modified by granisetron hydrochloride <content styleCode="italics">in vitro</content>.<br/>
                     <br/> In <content styleCode="italics">in vitro</content> human microsomal studies, ketoconazole inhibited ring oxidation of granisetron hydrochloride. However, the clinical significance of <content styleCode="italics">in vivo</content> pharmacokinetic interactions with ketoconazole is not known. In a human pharmacokinetic study, hepatic enzyme induction with phenobarbital resulted in a 25% increase in total plasma clearance of intravenous granisetron hydrochloride. The clinical significance of this change is not known.<br/>
                     <br/> QT prolongation has been reported with granisetron hydrochloride. Use of granisetron hydrochloride in patients concurrently treated with drugs known to prolong the QT interval and/or are arrhythmogenic may result in clinical consequences.<br/>
                     <br/> Serotonin syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT<sub>3</sub> receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) <content styleCode="italics">[see <linkHtml href="#Section_5.4">Warnings and Precautions (5.4)</linkHtml>]</content>.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Granisetron hydrochloride injection has been administered safely with benzodiazepines, neuroleptics, and anti-ulcer medications. <linkHtml href="#Section_7">(7)</linkHtml>
                           </item>
                           <item>Does not appear to interact with emetogenic cancer chemotherapies. <linkHtml href="#Section_7">(7)</linkHtml>
                           </item>
                           <item>Inducers or inhibitors of CYP450 enzymes may change the clearance and therefore the half-life of granisetron. <linkHtml href="#Section_7">(7)</linkHtml>
                           </item>
                           <item>Coadministration of granisetron hydrochloride with drugs known to prolong the QT interval and/or are arrhythmogenic may result in clinical consequences. <linkHtml href="#Section_7">(7)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
            </section>
         </component>
         <component>
            <section ID="Section_8">
               <id root="6b0adac0-b9c1-4bd7-87c6-03f84d750cb8"/>
               <code code="43684-0" codeSystem="2.16.840.1.113883.6.1" displayName="Use In Specific Populations Section"/>
               <title>8 USE IN SPECIFIC POPULATIONS</title>
               <effectiveTime value="20250424"/>
               <excerpt>
                  <highlight>
                     <text>
                        <list listType="unordered" styleCode="disc">
                           <item>Pregnancy: Use only if clearly needed. <linkHtml href="#Section_8.1">(8.1)</linkHtml>
                           </item>
                           <item>Nursing mothers: Caution should be exercised when administered to a nursing woman. <linkHtml href="#Section_8.3">(8.3)</linkHtml>
                           </item>
                           <item>Pediatric use: Safety and efficacy in pediatric patients have not been established for use in postoperative nausea and vomiting. <linkHtml href="#Section_8.4">(8.4)</linkHtml>
                           </item>
                           <item>Geriatric use: No differences in responses between the elderly and younger patients were observed in reported clinical experience. <linkHtml href="#Section_8.5">(8.5)</linkHtml>
                           </item>
                        </list>
                     </text>
                  </highlight>
               </excerpt>
               <component>
                  <section ID="Section_8.1">
                     <id root="84677011-f569-43a1-aa6b-fc639e6aad4d"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="Pregnancy Section"/>
                     <title>8.1 Pregnancy</title>
                     <text>
                        <br/>
                        <paragraph>
                           <content styleCode="italics">Teratogenic Effects</content>
                        </paragraph>
                        <br/>
                        <paragraph>Reproduction studies have been performed in pregnant rats at intravenous doses up toÂ 9 mg/kg/day (54 mg/m<sup>2</sup>/day, 146 times the recommended human dose based on body surface area) and pregnant rabbits at intravenous doses up to 3 mg/kg/day (35.4 mg/m<sup>2</sup>/day, 96 times the recommended human dose based on body surface area) and have revealed no evidence of impaired fertility or harm to the fetus due to granisetron. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_8.3">
                     <id root="9344ac1d-3bf6-49c4-9fbf-26dbe5d47a4b"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="Nursing Mothers Section"/>
                     <title>8.3 Nursing Mothers</title>
                     <text>
                        <br/>
                        <paragraph>It is not known whether granisetron is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when granisetron hydrochloride injection is administered to a nursing woman.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_8.4">
                     <id root="a447102e-7384-487f-80f3-b758262e1508"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="Pediatric Use Section"/>
                     <title>8.4 Pediatric Use</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Chemotherapy-Induced Nausea and Vomiting<br/>
                           </content>
                           <content styleCode="italics">
                              <br/> [See <linkHtml href="#Section_2">Dosage and Administration (2)</linkHtml>] </content>for use in chemotherapy-induced nausea and vomiting in pediatric patients 2 to 16 years of age. Safety and effectiveness in pediatric patients under 2 years of age have not been established.<content styleCode="underline">
                              <br/>
                              <br/> Postoperative Nausea and Vomiting<br/>
                           </content>
                           <br/> Safety and efficacy have not been established in pediatric patients for the prevention of postoperative nausea and vomiting (PONV). Granisetron has been evaluated in a pediatric patient clinical trial for use in the prevention of PONV. Due to the lack of efficacy and the QT prolongation observed in this trial, use of granisetron for the prevention of PONV in children is not recommended. The trial was a prospective, multicenter, randomized, double-blind, parallel-group trial that evaluated 157 children aged 2 to 16 years who were undergoing elective surgery for tonsillectomy or adenotonsillectomy. The purpose of the trial was to assess two dose levels (20 mcg/kg and 40 mcg/kg) of intravenous granisetron in the prevention of PONV. There was no active comparator or placebo. The primary endpoint was total control of nausea and vomiting (defined as no nausea, vomiting/retching, or use of rescue medication) in the 24 hours following surgery. Efficacy was not established due to lack of a dose response.<br/>
                           <br/> The trial also included standard 12 lead ECGs performed pre-dose and after the induction of anesthesia. ECGs were repeated at the end of surgery after the administration of granisetron and just prior to reversal of anesthesia. QT prolongation was seen at both dose levels. Five patients in this trial experienced an increase of â¥ 60 msec in QTcF. In addition, there were two patients whose QTcF was â¥ 500 msec. Interpretation of the QTcF prolongation was confounded by multiple factors, including the use of concomitant medication and the lack of either a placebo or active control. A thorough QT trial in adults has not been performed.<br/>
                           <br/> Other adverse events that occurred in the study included: vomiting (5 to 8%), post-procedural hemorrhage (3 to 5%), and dehydration (0 to 5%).<br/>
                           <br/> Pediatric patients under 2 years of age have not been studied.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_8.5">
                     <id root="d3af8cb6-e0e1-40dd-9454-3c0398808720"/>
                     <code code="34082-8" codeSystem="2.16.840.1.113883.6.1" displayName="Geriatric Use Section"/>
                     <title>8.5 Geriatric Use</title>
                     <text>
                        <paragraph>During chemotherapy clinical trials, 713 patients 65 years of age or older received granisetron hydrochloride injection. The safety and effectiveness were similar in patients of various ages.<br/>
                           <br/> During postoperative nausea and vomiting clinical trials, 168 patients 65 years of age or older, of which 47 were 75 years of age or older, received granisetron hydrochloride injection. Clinical studies of granisetron hydrochloride injection did not include sufficient numbers of subjects aged 65 years and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_10">
               <id root="d585dd90-a0a6-4b13-a036-66124aed42f3"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="Overdosage Section"/>
               <title>10 OVERDOSAGE</title>
               <text>
                  <br/>
                  <paragraph>There is no specific antidote for granisetron hydrochloride injection overdosage. In case of overdosage, symptomatic treatment should be given. Overdosage of up to 38.5 mg of granisetron hydrochloride injection has been reported without symptoms or only the occurrence of a slight headache.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
            </section>
         </component>
         <component>
            <section ID="Section_11">
               <id root="8fd12e4b-bb78-4ccc-aca6-55e8bfa9070b"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="Description Section"/>
               <title>11 DESCRIPTION</title>
               <text>
                  <br/>
                  <paragraph>Granisetron hydrochloride injection, USP is a serotonin-3 (5-HT<sub>3</sub>) receptor antagonist. Chemically it is <content styleCode="italics">endo</content>-N-(9-methyl-9-azabicyclo [3.3.1] non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride with a molecular weight of 348.9 (312.4 free base). Its molecular formula is C<sub>18</sub>H<sub>24</sub>N<sub>4</sub>Oâ¢HCl, while its chemical structure is:</paragraph>
                  <br/>
                  <br/>
                  <renderMultiMedia referencedObject="MM1"/>
                  <br/>
                  <paragraph>Granisetron hydrochloride USP is a white or almost white powder that is readily soluble in water and normal saline at 20Â°C. Granisetron hydrochloride injection, USP is a clear, colorless, sterile, nonpyrogenic, aqueous solution for intravenous administration.<br/>
                     <br/> Granisetron hydrochloride injection, USP 1 mg/mL is available in 1 mL single-dose and 4 mL multiple-dose vials.<br/>
                     <br/> Each mL contains 1.12 mg granisetron hydrochloride USP equivalent to granisetron 1 mg; sodium chloride, 9 mg; citric acid, 2 mg; methylparaben, 1.8 mg and propylparaben, 0.2 mg, as preservatives, water for injection, q.s., sodium hydroxide and hydrochloric acid, as pH adjusters. The solution's pH ranges from 4.0 to 6.0.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>Granisetron Hydrochloride Chemical Structure</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="granisetron-str.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_12">
               <id root="9fa56ba2-8894-494a-b0b2-3161b78d40cf"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="Clinical Pharmacology Section"/>
               <title>12 CLINICAL PHARMACOLOGY</title>
               <effectiveTime value="20250424"/>
               <component>
                  <section ID="Section_12.1">
                     <id root="d52fc2a3-f442-4c4d-abfd-830096a60527"/>
                     <code code="43679-0" codeSystem="2.16.840.1.113883.6.1" displayName="Mechanism of Action Section"/>
                     <title>12.1 Mechanism of Action</title>
                     <text>
                        <br/>
                        <paragraph>Granisetron is a selective 5-hydroxytryptamine<sub>3</sub> (5-HT<sub>3</sub>) receptor antagonist with little or no affinity for other serotonin receptors, including 5-HT<sub>1</sub>; 5-HT<sub>1A</sub>; 5-HT<sub>1B/C</sub>; 5-HT<sub>2</sub>; for alpha<sub>1</sub>-, alpha<sub>2</sub>- or beta-adrenoreceptors; for dopamine-D<sub>2</sub>; or for histamine-H<sub>1</sub>; benzodiazepine; picrotoxin or opioid receptors.<br/>
                           <br/>Serotonin receptors of the 5-HT<sub>3</sub> type are located peripherally on vagal nerve terminals and centrally in the chemoreceptor trigger zone of the area postrema. During chemotherapy-induced vomiting, mucosal enterochromaffin cells release serotonin, which stimulates 5-HT<sub>3</sub> receptors. This evokes vagal afferent discharge and may induce vomiting. Animal studies demonstrate that, in binding to 5-HT<sub>3</sub> receptors, granisetron blocks serotonin stimulation and subsequent vomiting after emetogenic stimuli such as cisplatin. In the ferret animal model, a single granisetron injection prevented vomiting due to high-dose cisplatin or arrested vomiting within 5 to 30 seconds.<br/>
                           <br/>In most human studies, granisetron has had little effect on blood pressure, heart rate or ECG. No evidence of an effect on plasma prolactin or aldosterone concentrations has been found in other studies.<br/>
                           <br/>Granisetron hydrochloride injection exhibited no effect on oro-cecal transit time in normal volunteers given a single intravenous infusion of 50 mcg/kg or 200 mcg/kg. Single and multiple oral doses slowed colonic transit in normal volunteers.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_12.3">
                     <id root="5a1fb923-7c4f-4e15-99ae-f1981c616782"/>
                     <code code="43682-4" codeSystem="2.16.840.1.113883.6.1" displayName="Pharmacokinetics Section"/>
                     <title>12.3 Pharmacokinetics</title>
                     <text>
                        <br/>
                        <paragraph>
                           <content styleCode="bold">Chemotherapy-Induced Nausea and Vomiting</content>
                           <br/>
                           <br/> In adult cancer patients undergoing chemotherapy and in volunteers, mean pharmacokinetic data obtained from an infusion of a single 40 mcg/kg dose of granisetron hydrochloride injection are shown in Table 3. </paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="829.92">
                           <caption>TableÂ 3 Pharmacokinetic Parameters in Adult Cancer Patients Undergoing Chemotherapy and in Volunteers, Following a Single Intravenous 40 mcg/kg Dose of Granisetron Hydrochloride Injection 
			</caption>
                           <colgroup>
                              <col width="21.1538461538462%"/>
                              <col width="19.2307692307692%"/>
                              <col width="22.1153846153846%"/>
                              <col width="20.1923076923077%"/>
                              <col width="17.3076923076923%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="5">
                                    <sup>*</sup>Â 5-minute infusion. <br/>
                                    <sup>â </sup>Â 3-minute infusion.<br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"> Peak Plasma Concentration</content>
                                    <br/>
                                    <content styleCode="bold">(ng/mL)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Terminal Phase Plasma Half-Life</content>
                                    <br/>
                                    <content styleCode="bold">(h)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Total </content>
                                    <br/>
                                    <content styleCode="bold">Â Â Â Â Â Â ClearanceÂ Â Â Â Â Â  </content>
                                    <br/>
                                    <content styleCode="bold">(L/h/kg)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Volume of Distribution</content>
                                    <br/>
                                    <content styleCode="bold">(L/kg)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">
                                    <content styleCode="bold">Â  Cancer PatientsÂ Â Â Â Â Â  </content>
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â Â  Mean <br/>Â Â Â  Â Range<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">63.8<sup>*</sup>
                                    <br/>18 to 176<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">8.95<sup>*</sup>
                                    <br/>0.9 to 31.1<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.38<sup>*</sup>
                                    <br/>0.14 to 1.54<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">3.07<sup>*</sup>
                                    <br/>0.85 to 10.4<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">
                                    <content styleCode="bold">Â  Volunteers</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â Â  21 to 42 years<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â  Â Mean <br/>Â Â Â Â  Range<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">64.3<sup>â </sup>
                                    <br/>             11.2 to 182<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">4.91<sup>â </sup>
                                    <br/>0.88 to 15.2<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.79<sup>â </sup>
                                    <br/>0.2 to 2.56<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">3.04<sup>â </sup>
                                    <br/>1.68 to 6.13<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â Â  65 to 81 years <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â  Â Mean <br/>Â Â Â Â  Range<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">57<sup>â </sup>
                                    <br/>14.6 to 153<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">7.69<sup>â </sup>
                                    <br/>2.65 to 17.7<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.44<sup>â </sup>
                                    <br/>0.17 to 1.06<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">3.97<sup>â </sup>
                                    <br/>1.75 to 7.01<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>
                           <content styleCode="underline">Distribution </content>
                           <br/>
                           <br/> Plasma protein binding is approximately 65% and granisetron distributes freely between plasma and red blood cells.<content styleCode="underline">
                              <br/>
                              <br/> Metabolism</content>
                           <br/>
                           <br/> Granisetron metabolism involves N-demethylation and aromatic ring oxidation followed by conjugation. <content styleCode="italics">In vitro</content> liver microsomal studies show that granisetronâs major route of metabolism is inhibited by ketoconazole, suggestive of metabolism mediated by the cytochrome P-450 3A subfamily. Animal studies suggest that some of the metabolites may also have 5-HT<sub>3</sub> receptor antagonist activity.<content styleCode="underline">
                              <br/>
                              <br/> Elimination<br/>
                           </content>Â  <br/>Clearance is predominantly by hepatic metabolism. In normal volunteers, approximately 12% of the administered dose is eliminated unchanged in the urine in 48 hours. The remainder of the dose is excreted as metabolites, 49% in the urine, and 34% in the feces.<content styleCode="underline">
                              <br/>
                              <br/> Subpopulations</content>
                           <content styleCode="italics">
                              <br/>
                              <br/> Gender</content>
                           <br/>
                           <br/>There was high inter- and intra-subject variability noted in these studies. No difference in mean AUC was found between males and females, although males had a higher C<sub>max</sub> generally.<content styleCode="italics">
                              <br/>
                              <br/> Elderly</content>
                           <br/>
                           <br/>The ranges of the pharmacokinetic parameters in elderly volunteers (mean age 71 years), given a single 40 mcg/kg intravenous dose of granisetron hydrochloride injection, were generally similar to those in younger healthy volunteers; mean values were lower for clearance and longer for half-life in the elderly patients (see Table 3).<content styleCode="italics">
                              <br/>
                              <br/> Pediatric Patients</content>
                           <br/>
                           <br/>A pharmacokinetic study in pediatric cancer patients (2 to 16 years of age), given a singleÂ 40 mcg/kg intravenous dose of granisetron hydrochloride injection, showed that volume of distribution and total clearance increased with age. No relationship with age was observed for peak plasma concentration or terminal phase plasma half-life. When volume of distribution and total clearance are adjusted for body weight, the pharmacokinetics of granisetron are similar in pediatric and adult cancer patients.<content styleCode="italics">
                              <br/>
                              <br/> Renal Failure Patients</content>
                           <br/>
                           <br/>Total clearance of granisetron was not affected in patients with severe renal failure who received a single 40 mcg/kg intravenous dose of granisetron hydrochloride injection.<content styleCode="italics">
                              <br/>
                              <br/> Hepatically Impaired Patients</content>
                           <br/>
                           <br/> A pharmacokinetic study in patients with hepatic impairment due to neoplastic liver involvement showed that total clearance was approximately halved compared to patients without hepatic impairment. Given the wide variability in pharmacokinetic parameters noted in patients, dosage adjustment in patients with hepatic functional impairment is not necessary.<br/>
                           <content styleCode="bold">
                              <br/> Postoperative Nausea and Vomiting<br/>
                           </content>
                           <br/> In adult patients (age range, 18 to 64 years) recovering from elective surgery and receiving general balanced anesthesia, mean pharmacokinetic data obtained from a single 1 mg dose of granisetron hydrochloride injection administered intravenously over 30 seconds are shown in Table 4.</paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="100%">
                           <caption>Table 4 Pharmacokinetic Parameters in 16 Adult Surgical Patients Following a Single Intravenous 1 mg Dose of Granisetron Hydrochloride InjectionÂ Â Â Â   
			</caption>
                           <colgroup>
                              <col width="12.98%"/>
                              <col width="36.68%"/>
                              <col width="24.06%"/>
                              <col width="26.28%"/>
                           </colgroup>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Terminal Phase </content>
                                    <br/>
                                    <content styleCode="bold">Plasma Half-Life (h)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Total Clearance</content>
                                    <br/>
                                    <content styleCode="bold">(L/h/kg)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Volume of Distribution</content>
                                    <br/>
                                    <content styleCode="bold">(L/kg)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top">Mean<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">8.63<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.28<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">2.42<br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" align="center" valign="top">Range<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">1.77 to 17.73<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.07 to 0.71<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.71 to 4.13<br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>The pharmacokinetics of granisetron in patients undergoing surgery were similar to those seen in cancer patients undergoing chemotherapy.</paragraph>
                        <br/>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_13">
               <id root="0e8119af-e753-4905-81e7-aa3012a502e1"/>
               <code code="43680-8" codeSystem="2.16.840.1.113883.6.1" displayName="Nonclinical Toxicology Section"/>
               <title>13 NONCLINICAL TOXICOLOGY</title>
               <effectiveTime value="20250424"/>
               <component>
                  <section ID="Section_13.1">
                     <id root="3c22e476-62f3-4977-84ec-45d33ac8f160"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="Carcinogenesis &amp; Mutagenesis &amp; Impairment Of Fertility Section"/>
                     <title>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <br/>
                        <paragraph>In a 24-month carcinogenicity study, rats were treated orally with granisetron 1, 5 orÂ 50 mg/kg/day (6, 30 or 300 mg/m<sup>2</sup>/day). The 50 mg/kg/day dose was reduced to 25 mg/kg/day (150 mg/m<sup>2</sup>/day) during week 59 due to toxicity. For a 50 kg person of average height (1.46 m<sup>2 </sup>body surface area), these doses represent 16, 81 and 405 times the recommended clinical dose (0.37 mg/m<sup>2</sup>, iv) on a body surface area basis. There was a statistically significant increase in the incidence of hepatocellular carcinomas and adenomas in males treated with 5 mg/kg/dayÂ (30 mg/m<sup>2</sup>/day, 81 times the recommended human dose based on body surface area) and above, and in females treated with 25 mg/kg/day (150 mg/m<sup>2</sup>/day, 405 times the recommended human dose based on body surface area). No increase in liver tumors was observed at a dose ofÂ 1 mg/kg/day (6 mg/m<sup>2</sup>/day, 16 times the recommended human dose based on body surface area) in males and 5 mg/kg/day (30 mg/m<sup>2</sup>/day, 81 times the recommended human dose based on body surface area) in females. In a 12-month oral toxicity study, treatment with granisetronÂ 100 mg/kg/day (600 mg/m<sup>2</sup>/day, 1622 times the recommended human dose based on body surface area) produced hepatocellular adenomas in male and female rats while no such tumors were found in the control rats. A 24-month mouse carcinogenicity study of granisetron did not show a statistically significant increase in tumor incidence, but the study was not conclusive.<br/>
                           <br/>Because of the tumor findings in rat studies, granisetron hydrochloride injection should be prescribed only at the dose and for the indication recommended <content styleCode="italics">[see <linkHtml href="#Section_1">Indications and Usage (1)</linkHtml> and <linkHtml href="#Section_2">Dosage and Administration (2)</linkHtml>]</content>.<br/>
                           <br/>Granisetron was not mutagenic in an <content styleCode="italics">in vitro</content> Ames test and mouse lymphoma cell forward mutation assay, and <content styleCode="italics">in vivo</content> mouse micronucleus test and <content styleCode="italics">in vitro</content> and <content styleCode="italics">ex vivo</content> rat hepatocyte UDS assays. It, however, produced a significant increase in UDS in HeLa cells <content styleCode="italics">in vitro</content> and a significant increased incidence of cells with polyploidy in an <content styleCode="italics">in vitro</content> human lymphocyte chromosomal aberration test.<br/>
                           <br/> Granisetron at subcutaneous doses up to 6 mg/kg/day (36 mg/m<sup>2</sup>/day, 97 times the recommended human dose based on body surface area) was found to have no effect on fertility and reproductive performance of male and female rats.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_14">
               <id root="baf8f9bf-5bfd-4729-836d-eb325493d066"/>
               <code code="34092-7" codeSystem="2.16.840.1.113883.6.1" displayName="Clinical Studies Section"/>
               <title>14 CLINICAL STUDIES</title>
               <effectiveTime value="20250424"/>
               <component>
                  <section ID="Section_14.1">
                     <id root="9cc7fd2e-1cd4-4b10-b962-eb4770d87db9"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>14.1 Chemotherapy-Induced Nausea and Vomiting</title>
                     <text>
                        <br/>
                        <paragraph>
                           <content styleCode="underline">Single-Day Chemotherapy</content>
                           <content styleCode="italics">
                              <br/>
                              <br/> Cisplatin-Based Chemotherapy</content>
                           <br/>
                           <br/> In a double-blind, placebo-controlled study in 28 cancer patients, granisetron hydrochloride injection, administered as a single intravenous infusion of 40 mcg/kg, was significantly more effective than placebo in preventing nausea and vomiting induced by cisplatin chemotherapy (see Table 5). </paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="829.92">
                           <caption>TableÂ 5 Prevention of Chemotherapy-Induced Nausea and Vomiting â Single-Day Cisplatin Therapy<sup>1</sup>
                           </caption>
                           <colgroup>
                              <col width="31.7307692307692%"/>
                              <col width="29.8076923076923%"/>
                              <col width="20.1923076923077%"/>
                              <col width="18.2692307692308%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="4">
                                    <sup>1 </sup>Cisplatin administration began within 10 minutes of granisetron hydrochloride injection infusion and continued for 1.5 to 3 hours. Mean cisplatin dose was 86 mg/m<sup>2 </sup>in the granisetron hydrochloride injection group and 80 mg/m<sup>2 </sup>in the placebo group.<br/>
                                    <sup/>
                                    <sup>2</sup> No vomiting and no moderate or severe nausea. <br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">Granisetron Hydrochloride Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"> Placebo </content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">P-Value </content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">14<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">14<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Response Over 24 Hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â  Complete Response<sup>2</sup>
                                    <br/>Â  No Vomiting<br/>Â  No More Than Mild Nausea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">93%<br/>93%<br/>93%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">7%<br/>14%<br/>7%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">&lt; 0.001<br/>&lt; 0.001<br/>&lt; 0.001<br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>Granisetron hydrochloride injection was also evaluated in a randomized dose response study of cancer patients receiving cisplatin â¥ 75 mg/m<sup>2</sup>. Additional chemotherapeutic agents included: anthracyclines, carboplatin, cytostatic antibiotics, folic acid derivatives, methylhydrazine, nitrogen mustard analogs, podophyllotoxin derivatives, pyrimidine analogs, and vinca alkaloids. Granisetron hydrochloride injection doses of 10 and 40 mcg/kg were superior to 2 mcg/kg in preventing cisplatin-induced nausea and vomiting, but 40 mcg/kg was not significantly superior to 10 mcg/kg (see Table 6). </paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="823.27">
                           <caption>TableÂ 6 Prevention of Chemotherapy-Induced Nausea and Vomiting â Single-Day High-Dose Cisplatin Therapy<sup>1</sup>
                           </caption>
                           <colgroup>
                              <col width="39.7415185783522%"/>
                              <col width="12.6009693053312%"/>
                              <col width="14.5395799676898%"/>
                              <col width="11.7932148626817%"/>
                              <col width="11.6316639741519%"/>
                              <col width="9.69305331179321%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="6">
                                    <sup>1</sup> Cisplatin administration began within 10 minutes of granisetron hydrochloride injection infusion and continued for 2.6 hours (mean). Mean cisplatin doses were 96 to 99 mg/m<sup>2</sup>. <br/>
                                    <sup>2</sup> No vomiting and no moderate or severe nausea. <br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" rowspan="2" valign="top">
                                    <br/>
                                    <content styleCode="bold"/>
                                 </td>
                                 <td styleCode="Rrule" colspan="3" align="center" valign="top">
                                    <content styleCode="bold"> Granisetron Hydrochloride Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                    <content styleCode="bold"> (mcg/kg)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" colspan="2" align="center" valign="top">
                                    <content styleCode="bold">P-Value </content>
                                    <br/>
                                    <content styleCode="bold">(vs. 2 mcg/kg)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top">
                                    <content styleCode="bold">2</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">10</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">40</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">10</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">40</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">52<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">52<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">53<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Response Over 24 Hours <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â  Complete Response<sup>2</sup>
                                    <br/>Â  No Vomiting <br/>Â  No More Than Mild Nausea<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">31%<br/>38%<br/>58%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">62%<br/>65%<br/>75%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">68%<br/>74%<br/>79%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">&lt; 0.002<br/>&lt; 0.001<br/>NS<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">&lt; 0.001<br/>&lt; 0.001<br/>0.007<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>Granisetron hydrochloride injection was also evaluated in a double-blind, randomized dose response study of 353 patients stratified for high (â¥ 80 to 120 mg/m<sup>2</sup>) or low (50 to 79 mg/m<sup>2</sup>) cisplatin dose. Response rates of patients for both cisplatin strata are given in Table 7.</paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="821.94">
                           <caption>TableÂ 7 Prevention of Chemotherapy-Induced Nausea and Vomiting â Single-Day High-Dose and Low-Dose Cisplatin Therapy<sup>1</sup>
                           </caption>
                           <colgroup>
                              <col width="35.9223300970874%"/>
                              <col width="9.70873786407767%"/>
                              <col width="8.7378640776699%"/>
                              <col width="8.7378640776699%"/>
                              <col width="9.70873786407767%"/>
                              <col width="9.70873786407767%"/>
                              <col width="8.7378640776699%"/>
                              <col width="8.7378640776699%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="8">
                                    <sup>1</sup> Cisplatin administration began within 10 minutes of granisetron hydrochloride injection infusion and continued for 2 hours (mean). Mean cisplatin doses were 64 and 98 mg/m<sup>2</sup> for low and high strata.<br/>
                                    <sup>2</sup> No vomiting and no use of rescue antiemetic. <br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" rowspan="2" valign="top"/>
                                 <td styleCode="Rrule" colspan="4" align="center" valign="top">
                                    <content styleCode="bold"> Granisetron Hydrochloride Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                    <content styleCode="bold"> (mcg/kg)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" colspan="3" align="center" valign="middle">
                                    <content styleCode="bold">P-Value</content>
                                    <br/>
                                    <content styleCode="bold">(vs. 5 mcg/kg)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top">
                                    <content styleCode="bold">5</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">10</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">20</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">40</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">10</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">20</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">40</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">
                                    <content styleCode="bold">Â  High-Dose Cisplatin</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">40<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">49<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">48<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">47<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Response Over 24 Hours<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â Â  Complete Response<sup>2</sup>
                                    <br/>Â Â Â Â  No Vomiting<br/>Â Â Â Â  No Nausea<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">18%<br/>28%<br/>15%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">41%<br/>47%<br/>35%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">40%<br/>44%<br/>38%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">47%<br/>53%<br/>43%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.018<br/>NS<br/>0.036<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.025<br/>NS<br/>0.019<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.004<br/>0.016<br/>0.005<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">
                                    <content styleCode="bold"> Â  Low-Dose Cisplatin</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">42<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">41<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">40<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">46<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Response Over 24 Hours<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â Â Â Â  Complete Response<sup>2</sup>
                                    <br/>Â Â Â Â  No Vomiting<br/>Â Â Â Â  No Nausea<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">29%<br/>36%<br/>29%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">56%<br/>63%<br/>56%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">58%<br/>65%<br/>38%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">41%<br/>43%<br/>33%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.012<br/>0.012<br/>0.012<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">0.009<br/>0.008<br/>NS<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">NS<br/>NS<br/>NS<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>For both the low and high cisplatin strata, the 10, 20, and 40 mcg/kg doses were more effective than the 5 mcg/kg dose in preventing nausea and vomiting within 24 hours of chemotherapy administration. The 10 mcg/kg dose was at least as effective as the higher doses.<br/>
                           <content styleCode="italics">
                              <br/> Moderately Emetogenic Chemotherapy</content>
                           <br/>
                           <br/> Granisetron hydrochloride injection, 40 mcg/kg, was compared with the combination of chlorpromazine (50 to 200 mg/24 hours) and dexamethasone (12 mg) in patients treated with moderately emetogenic chemotherapy, including primarily carboplatin &gt; 300 mg/m<sup>2</sup>, cisplatin 20 to 50 mg/m<sup>2</sup> and cyclophosphamide &gt; 600 mg/m<sup>2</sup>. Granisetron hydrochloride injection was superior to the chlorpromazine regimen in preventing nausea and vomiting (see Table 8). </paragraph>
                        <br/>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="829.92">
                           <caption>TableÂ 8 Prevention of Chemotherapy-Induced Nausea and VomitingâSingle-Day Moderately Emetogenic Chemotherapy  
			</caption>
                           <colgroup>
                              <col width="31.7307692307692%"/>
                              <col width="29.8076923076923%"/>
                              <col width="23.0769230769231%"/>
                              <col width="15.3846153846154%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="4">
                                    <sup>1</sup> Patients also received dexamethasone, 12 mg. <br/>
                                    <sup>2</sup> No vomiting and no moderate or severe nausea. <br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"> Granisetron Hydrochloride Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"> Chlorpromazine<sup>1 </sup>
                                    </content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">P-Value </content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">133<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">133<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="top">Â  Response Over 24 Hours<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â  Complete Response<sup>2</sup>
                                    <br/>Â  No Vomiting<br/>Â  No More Than Mild Nausea<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">68%<br/>73%<br/>77%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">47%<br/>53%<br/>59%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">&lt; 0.001<br/>&lt; 0.001<br/>&lt; 0.001<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>In other studies of moderately emetogenic chemotherapy, no significant difference in efficacy was found between granisetron hydrochloride doses of 40 mcg/kg and 160 mcg/kg.<content styleCode="underline">
                              <br/>
                              <br/> Repeat-Cycle Chemotherapy</content>
                           <br/>
                           <br/> In an uncontrolled trial, 512 cancer patients received  granisetron hydrochloride injection, 40 mcg/kg, prophylactically, for two cycles of chemotherapy, 224 patients received it for at least four cycles, and 108 patients received it for at least six cycles. Granisetron hydrochloride injection efficacy remained relatively constant over the first six repeat cycles, with complete response rates (no vomiting and no moderate or severe nausea in 24 hours) of 60% to 69%. No patients were studied for more than 15 cycles.<content styleCode="underline">
                              <br/>
                              <br/> Pediatric Studies</content>
                           <br/>
                           <br/> A randomized double-blind study evaluated the 24-hour response of 80 pediatric cancer patients (age 2 to 16 years) to granisetron hydrochloride injection 10, 20 or 40 mcg/kg. Patients were treated with cisplatin â¥ 60 mg/m<sup>2</sup>, cytarabine â¥ 3 g/m<sup>2</sup>, cyclophosphamide â¥ 1 g/m<sup>2</sup> or nitrogen mustard â¥ 6 mg/m<sup>2</sup> (see Table 9). </paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="821.94">
                           <caption>Table 9 Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients 
			</caption>
                           <colgroup>
                              <col width="43.6893203883495%"/>
                              <col width="22.3300970873786%"/>
                              <col width="17.4757281553398%"/>
                              <col width="16.504854368932%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="4">
                                    <sup>1</sup> No vomiting and no moderate or severe nausea. <br/>
                                 </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" rowspan="2" valign="top">
                                    <br/>
                                    <content styleCode="bold"/>
                                 </td>
                                 <td styleCode="Rrule" colspan="3" align="center" valign="top">
                                    <content styleCode="bold"> Granisetron Hydrochloride Injection</content>
                                    <content styleCode="bold"> Dose</content>
                                    <br/>
                                    <content styleCode="bold">(mcg/kg)</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="top">
                                    <content styleCode="bold">10</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">20</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">
                                    <content styleCode="bold">40</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="top">Â  Number of Patients<br/>Â  Median Number of Vomiting Episodes<br/>Â  Complete Response Over 24 Hours<sup>1</sup>
                                    <content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">29<br/>2<br/>21%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">26<br/>3<br/>31%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top">25<br/>1<br/>32%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <br/>
                        <paragraph>A second pediatric study compared granisetron hydrochloride injection 20 mcg/kg to chlorpromazine plus dexamethasone in 88 patients treated with ifosfamide â¥ 3 g/m<sup>2</sup>/day for two or three days. Granisetron hydrochloride injection was administered on each day of ifosfamide treatment. At 24 hours, 22% of granisetron hydrochloride injection patients achieved complete response (no vomiting and no moderate or severe nausea in 24 hours) compared with 10% on the chlorpromazine regimen. The median number of vomiting episodes with granisetron hydrochloride injection was 1.5; with chlorpromazine it was 7.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
               <component>
                  <section ID="Section_14.3">
                     <id root="937c5bd2-01a0-4b61-8889-5f747f501c05"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>14.2 Postoperative Nausea and Vomiting</title>
                     <text>
                        <paragraph>
                           <content styleCode="underline">Prevention of Postoperative Nausea and Vomiting<br/>
                           </content>
                           <br/> The efficacy of granisetron hydrochloride injection for prevention of postoperative nausea and vomiting was evaluated in 868 patients, of which 833 were women, 35 men, 484 Caucasians, 348 Asians, 18 Blacks, 18 Other, with 61 patients 65 years or older. Granisetron hydrochloride injection was evaluated in two randomized, double-blind, placebo-controlled studies in patients who underwent elective gynecological surgery or cholecystectomy and received general anesthesia. Patients received a single intravenous dose of granisetron hydrochloride injection (0.1 mg, 1 mg or 3 mg) or placebo either 5 minutes before induction of anesthesia or immediately before reversal of anesthesia. The primary endpoint was the proportion of patients with no vomiting for 24 hours after surgery. Episodes of nausea and vomiting and use of rescue antiemetic therapy were recorded for 24 hours after surgery. In both studies, granisetron hydrochloride injection (1 mg) was more effective than placebo in preventing postoperative nausea and vomiting (see Table 10). No additional benefit was seen in patients who received the 3 mg dose.</paragraph>
                        <br/>
                        <table cellspacing="0" cellpadding="0" border="0" width="100%">
                           <caption>Table 10 Prevention of Postoperative Nausea and Vomiting in Adult PatientsÂ Â Â   
			</caption>
                           <colgroup>
                              <col width="22.14%"/>
                              <col width="17.86%"/>
                              <col width="20%"/>
                              <col width="20%"/>
                              <col width="20%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="85">*P&lt;0.05<br/>         **P&lt;0.001 versus placebo<br/>         Note: No Vomiting = no vomiting and no use of rescue antiemetic therapy; No Nausea = no nausea and no use of rescue antiemetic therapyÂ Â Â Â  </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Study and Efficacy Endpoint</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <br/>
                                    <content styleCode="bold">0.1 mg</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <br/>
                                    <content styleCode="bold">1 mg</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <br/>
                                    <content styleCode="bold">3 mg</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Study 1</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                                 <td styleCode="Rrule" align="center" valign="top"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Number of Patients</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">133</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">132</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">134</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">128</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">No Vomiting</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">34%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">45%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">63%**<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">62%**<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">22%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">28%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">50%**<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">42%**<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea or Vomiting<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">18%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">27%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">49%**<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">42%**<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Use of Rescue Antiemetic Therapy<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">60%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">67%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">75%*<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">77%*<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Study 2</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Number of Patients</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">117</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">â</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">110</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">114</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Vomiting<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">56%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">77%**<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">75%*<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">37%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">59%**<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">56%*<br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="italics">Gender/Race<br/>
                           </content>
                           <br/> There were too few male and Black patients to adequately assess differences in effect in either population.<br/>
                           <content styleCode="underline">
                              <br/> Treatment of Postoperative Nausea and Vomiting<br/>
                           </content>
                           <br/> The efficacy of granisetron hydrochloride injection for treatment of postoperative nausea and vomiting was evaluated in 844 patients, of which 731 were women, 113 men, 777 Caucasians, 6Â Asians, 41 Blacks, 20 Other, with 107 patients 65 years or older. Granisetron hydrochloride injection was evaluated in two randomized, double-blind, placebo-controlled studies of adult surgical patients who received general anesthesia with no prophylactic antiemetic agent, and who experienced nausea or vomiting within 4 hours postoperatively. Patients received a single intravenous dose of granisetron hydrochloride injection (0.1 mg, 1 mg or 3 mg) or placebo after experiencing postoperative nausea or vomiting. Episodes of nausea and vomiting and use of rescue antiemetic therapy were recorded for 24 hours after administration of study medication. Granisetron hydrochloride injection was more effective than placebo in treating postoperative nausea and vomiting (see Table 11). No additional benefit was seen in patients who received the 3 mg dose. </paragraph>
                        <table cellspacing="0" cellpadding="0" border="0" width="100%">
                           <caption>Table 11 Treatment of Postoperative Nausea and Vomiting in Adult PatientsÂ Â Â Â Â   
			</caption>
                           <colgroup>
                              <col width="39.02%"/>
                              <col width="15.24%"/>
                              <col width="15.26%"/>
                              <col width="15.22%"/>
                              <col width="15.26%"/>
                           </colgroup>
                           <tfoot>
                              <tr>
                                 <td colspan="150">*P&lt;0.05<br/>         **P&lt;0.01<br/>         ***P&lt;0.001 versus placebo<br/>         1 Protocol Specified Analysis: Patients who had vomiting prior to treatment<br/>         Note: No vomiting = no vomiting and no use of rescue antiemetic therapy; No nausea = no nausea and no use of rescue antiemetic therapyÂ Â Â Â  </td>
                              </tr>
                           </tfoot>
                           <tbody>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Study and Efficacy Endpoint</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Placebo</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                    <content styleCode="bold">0.1 mg</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                    <content styleCode="bold">1 mg</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">Granisetron</content>
                                    <br/>
                                    <content styleCode="bold">Hydrochloride</content>
                                    <br/>
                                    <content styleCode="bold">Injection</content>
                                    <content styleCode="bold"/>
                                    <br/>
                                    <content styleCode="bold">3 mg</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" align="justify" valign="top">
                                    <content styleCode="bold">Study 3</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="justify" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="justify" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="justify" valign="top">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="justify" valign="top">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Number of Patients</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">133</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">128</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">133</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">125</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Vomiting<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">26%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">53%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">58%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">60%***<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">20%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">38%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">46%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">49%***<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">17%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">40%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">41%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">42%***<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">13%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">27%**<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">30%**<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">37%***<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Use of Rescue Antiemetic Therapy<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">33%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">51%**<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">61%***<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">61%***<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Study 4</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Number of Patients (All Patients)</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">162</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">163</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">â</content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">
                                    <content styleCode="bold">â</content>
                                    <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Vomiting<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">20%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">32%*<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">14%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">23%*<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">13%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">18%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">9%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">14%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Nausea or Vomiting<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">13%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">18%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">9%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">14%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Use of Rescue Antiemetic Therapy<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">24%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">34%*<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">
                                    <content styleCode="bold">Number of Patients (Treated for Vomiting)<sup>1</sup>
                                    </content>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">86<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">103<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<br/>
                                 </td>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">No Vomiting<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">Â <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                                 <td styleCode="Rrule" align="center" valign="middle"/>
                              </tr>
                              <tr styleCode="Botrule">
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 6 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">21%<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">27%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                              <tr>
                                 <td styleCode="Lrule Rrule" valign="middle">0 to 24 hours<br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">14%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">20%<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<content styleCode="bold"/>
                                    <br/>
                                 </td>
                                 <td styleCode="Rrule" align="center" valign="middle">â<content styleCode="bold"/>
                                    <br/>
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <paragraph>
                           <content styleCode="italics">Gender/Race<br/>
                           </content>
                           <br/> There were too few male and Black patients to adequately assess differences in effect in either population.</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_16">
               <id root="77662cc7-4971-4b72-a63b-f9aa9e3427d2"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="How Supplied Section"/>
               <title>16 HOW SUPPLIED/STORAGE AND HANDLING</title>
               <text>
                  <br/>
                  <paragraph>Granisetron hydrochloride injection USP, 1 mg/mL (free base), is supplied in 1 mL Single-Dose Vials and 4 mg/4 mL Multiple-Dose Vials.<content styleCode="bold">
                        <content styleCode="underline">
                           <br/>
                           <br/> 1 mg (base) per mL:<br/>
                        </content>
                     </content>
                     <br/> Â Â Â Single-Dose Vials in a carton of 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  Â Â Â NDC 55150-175-01<content styleCode="bold">
                        <content styleCode="underline">
                           <br/>
                           <br/> 4 mg per 4 mL (1 mg (base)/mL):<br/>
                        </content>
                     </content>
                     <br/> Â Â Â Multiple-Dose Vials in a carton of 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  NDC 55150-176-04<content styleCode="bold">
                        <br/>
                        <br/> Store at </content>20Â° to 25Â°C (68Â° to 77Â°F) [see USP Controlled Room Temperature].<br/>
                     <br/> Discard unused portion for the single-dose vials.<br/>
                     <br/> Once the multiple-dose vial is penetrated, its contents should be used within 30 days.<br/>
                     <br/>
                     <content styleCode="bold">Do not freeze. Protect from light. Retain in carton until time of use.<br/>
                        <br/>
                     </content>The vial stopper is not made with natural rubber latex.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
            </section>
         </component>
         <component>
            <section ID="Section_17">
               <id root="a2cb0fbf-ac43-416c-86f0-3f9e010ef35a"/>
               <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="Information For Patients Section"/>
               <title>17 PATIENT COUNSELING INFORMATION</title>
               <text>
                  <paragraph>Patients should be informed that the most common adverse reactions for the indication of chemotherapy induced nausea and vomiting are headache and constipation (see Table 1).<br/>
                     <br/> Patients should be informed that the most common adverse reactions for the indication of postoperative nausea and vomiting are pain, headache, fever, abdominal pain and hepatic enzyme increased (see Table 2).<br/>
                     <br/> Patients should be advised of the risk of allergic reactions if they have a prior allergic reaction to a class of antiemetics known as 5-HT<sub>3</sub> receptor antagonists.<br/>
                     <br/> Electrocardiogram changes (QT prolongation) have been reported with the use of granisetron hydrochloride. Patients should be cautioned about the use of this drug if they have heart problems or take medications for heart problems.</paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <section ID="Section_17.1">
                     <id root="482720c0-778c-4a22-8be1-afefeb305cb4"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="Spl Unclassified Section"/>
                     <title>17.1 Serotonin Syndrome</title>
                     <text>
                        <paragraph>Advise patients of the possibility of serotonin syndrome with concomitant use of granisetron and another serotonergic agent such as medications to treat depression and migraines. Advise patients to seek immediate medical attention if the following symptoms occur: changes in mental status, autonomic instability, neuromuscular symptoms with or without gastrointestinal symptoms.<br/>
                           <br/> Distributed by:<br/>
                           <content styleCode="bold">Eugia US LLC<br/>
                           </content>279 Princeton-Hightstown Rd.<br/>E. Windsor, NJ 08520<br/>
                           <br/> Manufactured by:<br/>
                           <content styleCode="bold">Eugia Pharma Specialities Limited<br/>
                           </content>Hyderabad - 500032<br/>India</paragraph>
                     </text>
                     <effectiveTime value="20250424"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_19">
               <id root="375e567d-9a01-4117-947c-5858b50696f2"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg (base) per mL - 1 mL Container Label</title>
               <text>
                  <br/>
                  <paragraph>
                     <content styleCode="bold">Rx onlyÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  NDC</content>Â <content styleCode="bold">55150-175-01</content>
                     <br/>
                     <content styleCode="bold">Granisetron<br/> Hydrochloride<br/> Injection, USP <br/> 1 mg (base) per mL <br/> For Intravenous<br/> use only <br/> 1 mLÂ Single-Dose VialÂ <br/>
                        <br/>
                     </content>
                  </paragraph>
                  <renderMultiMedia referencedObject="MM2"/>
                  <br/>
                  <br/>
                  <br/>
                  <br/>
                  <br/>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <observationMedia ID="MM2">
                     <text>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg (base) per mL - 1 mL Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="granisetron-fig1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_20">
               <id root="def5b71e-f6a1-450e-bbd0-3d7f6fbe8c1c"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg (base) per mL - Container-Carton [1 Vial]</title>
               <text>
                  <br/>
                  <paragraph>
                     <content styleCode="bold">Rx onlyÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  NDC </content>
                     <content styleCode="bold">55150-175-01</content>
                     <br/>
                     <content styleCode="bold">Granisetron<br/> Hydrochloride<br/> Injection, USP<br/> 1 mg (base) per mL<br/> For Intravenous use only<br/> Sterile<br/> 1 mL Single-Dose Vial<br/> eugia<br/>
                        <br/>
                        <renderMultiMedia referencedObject="MM3"/>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <observationMedia ID="MM3">
                     <text>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 1 mg (base) per mL - Container-Carton [1 Vial]</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="granisetron-fig2.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_21">
               <id root="342f0387-cd6f-4d51-a556-89fc5cc539e0"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 4 mL (1 mg (base)/mL) - 4 mL Container Label</title>
               <text>
                  <br/>
                  <paragraph>
                     <content styleCode="bold">Rx onlyÂ Â Â Â Â Â Â Â Â Â Â Â Â Â  NDC </content>
                     <content styleCode="bold">55150-176-04<br/> Granisetron<br/> Hydrochloride<br/> Injection, USP<br/> 4 mg per 4 mL<br/> (1 mg (base)/mL)<br/> For Intravenous<br/> use only<br/> 4 mLÂ Multiple-Dose Vial<br/>
                        <br/>
                        <renderMultiMedia referencedObject="MM4"/>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <observationMedia ID="MM4">
                     <text>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 4 mL (1 mg (base)/mL) - 4 mL Container Label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="granisetron-fig3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="Section_22">
               <id root="7d03eda1-bd3d-47e2-ac7c-58b855da7adc"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 4 mL (1 mg (base)/mL) - Container-Carton [1 Vial]</title>
               <text>
                  <br/>
                  <paragraph>
                     <content styleCode="bold">Rx onlyÂ Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  NDC</content>Â <content styleCode="bold">55150-176-04</content>
                     <br/>
                     <content styleCode="bold">Granisetron<br/> Hydrochloride<br/> Injection, USP<br/> 4 mg per 4 mL<br/> (1 mg (base)/mL)<br/> For Intravenous use only<br/> Sterile<br/> 4 mL Multiple-Dose Vial<br/> eugia<br/>
                        <br/>
                        <renderMultiMedia referencedObject="MM5"/>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20250424"/>
               <component>
                  <observationMedia ID="MM5">
                     <text>PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 4 mg per 4 mL (1 mg (base)/mL) - Container-Carton [1 Vial]</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="granisetron-fig4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>